Paper41010669
Targeting Mitochondrial Reactive Oxygen Species: JP4-039's Potential as a Cardiovascular Therapeutic.
Yalamanchili K and 6 others. J Clin Med, 2025. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Targeting Mitochondrial Reactive Oxygen Species: JP4-039's Potential as a Cardiovascular Therapeutic. Papers, record 41010669. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41010669
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Targeting Mitochondrial Reactive Oxygen Species: JP4-039's Potential as a Cardiovascular Therapeutic.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants9
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 HL046716 | NHLBI NIH HHS | United States | R01HL046716 | PubMed | NIH RePORTER |
| T32 HL160517 | NHLBI NIH HHS | United States | T32HL160517 | PubMed and NIH | NIH RePORTER |
| R56 HL133624 | NHLBI NIH HHS | United States | R56HL133624 | PubMed | NIH RePORTER |
| P30 GM145500 | NIGMS NIH HHS | United States | P30GM145500 | PubMed and NIH | NIH RePORTER |
| R01 HL175045 | NHLBI NIH HHS | United States | R01HL175045 | PubMed and NIH | NIH RePORTER |
| P20 GM103652 | NIGMS NIH HHS | United States | P20GM103652 | PubMed | NIH RePORTER |
| R01 HL128831 | NHLBI NIH HHS | United States | R01HL128831 | PubMed | NIH RePORTER |
| 1R56HL613362-03 | NIH HHS | United States | R56HL613362 | PubMed | NIH RePORTER |
| R01 HL133624 | NHLBI NIH HHS | United States | R01HL133624 | PubMed | NIH RePORTER |
References150
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19581509 | Mitochondria-targeted antioxidant MitoQ10 improves endothelial function and attenuates cardiac hypertrophy. | Hypertension | 2009 | https://conductscience.org/library/papers/19581509 | PubMed |
| 2 | 31270248 | JNK and cardiometabolic dysfunction. | Biosci Rep | 2019 | https://conductscience.org/library/papers/31270248 | PubMed |
| 3 | 27143992 | The Reactive Oxygen Species in Macrophage Polarization: Reflecting Its Dual Role in Progression and Treatment of Human Diseases. | Oxid Med Cell Longev | 2016 | https://conductscience.org/library/papers/27143992 | PubMed |
| 4 | 33917009 | Role of Creatine in the Heart: Health and Disease. | Nutrients | 2021 | https://conductscience.org/library/papers/33917009 | PubMed |
| 5 | 30067872 | Inhibition of JNK and p38 MAPK-mediated inflammation and apoptosis by ivabradine improves cardiac function in streptozotocin-induced diabetic cardiomyopathy. | J Cell Physiol | 2019 | https://conductscience.org/library/papers/30067872 | PubMed |
| 6 | 24361238 | p38α regulates SERCA2a function. | J Mol Cell Cardiol | 2014 | https://conductscience.org/library/papers/24361238 | PubMed |
| 7 | 24702237 | Endoplasmic reticulum stress and oxidative stress in cell fate decision and human disease. | Antioxid Redox Signal | 2014 | https://conductscience.org/library/papers/24702237 | PubMed |
| 8 | 34426760 | Reactive Oxygen Species (ROS) Regulates Different Types of Cell Death by Acting as a Rheostat. | Oxid Med Cell Longev | 2021 | https://conductscience.org/library/papers/34426760 | PubMed |
| 9 | 26083760 | Long-term increase in coherence between the basal ganglia and motor cortex after asphyxial cardiac arrest and resuscitation in developing rats. | Pediatr Res | 2015 | https://conductscience.org/library/papers/26083760 | PubMed |
| 10 | 23258542 | Inhibition of JNK mitochondrial localization and signaling is protective against ischemia/reperfusion injury in rats. | J Biol Chem | 2013 | https://conductscience.org/library/papers/23258542 | PubMed |
| 11 | 36313628 | The role of BCL-2 family proteins in regulating apoptosis and cancer therapy. | Front Oncol | 2022 | https://conductscience.org/library/papers/36313628 | PubMed |
| 12 | 32380253 | Exercise-induced oxidative stress: Friend or foe? | J Sport Health Sci | 2020 | https://conductscience.org/library/papers/32380253 | PubMed |
| 13 | 35204116 | Inflammatory Cells in Atherosclerosis. | Antioxidants (Basel) | 2022 | https://conductscience.org/library/papers/35204116 | PubMed |
| 14 | 25206509 | Oxidative stress, mitochondrial damage and neurodegenerative diseases. | Neural Regen Res | 2013 | https://conductscience.org/library/papers/25206509 | PubMed |
| 15 | 30177881 | Targeting Mitochondrial Oxidative Stress to Mitigate UV-Induced Skin Damage. | Front Pharmacol | 2018 | https://conductscience.org/library/papers/30177881 | PubMed |
| 16 | 29749471 | GSK3β‑mediated Ser156 phosphorylation modulates a BH3‑like domain in BCL2L12 during TMZ‑induced apoptosis and autophagy in glioma cells. | Int J Mol Med | 2018 | https://conductscience.org/library/papers/29749471 | PubMed |
| 17 | 29391546 | The GS-nitroxide JP4-039 improves intestinal barrier and stem cell recovery in irradiated mice. | Sci Rep | 2018 | https://conductscience.org/library/papers/29391546 | PubMed |
| 18 | 24859228 | Mitochondrial JNK activation triggers autophagy and apoptosis and aggravates myocardial injury following ischemia/reperfusion. | Biochim Biophys Acta | 2015 | https://conductscience.org/library/papers/24859228 | PubMed |
| 19 | 29540694 | The mitochondrially targeted antioxidant MitoQ protects the intestinal barrier by ameliorating mitochondrial DNA damage via the Nrf2/ARE signaling pathway. | Cell Death Dis | 2018 | https://conductscience.org/library/papers/29540694 | PubMed |
| 20 | 37268435 | Efficacy and Safety of Elamipretide in Individuals With Primary Mitochondrial Myopathy: The MMPOWER-3 Randomized Clinical Trial. | Neurology | 2023 | https://conductscience.org/library/papers/37268435 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42625977 | Aortic dissection as a disease of vascular wall homeostasis: integrating vasa vasorum-inflammation-metabolism axis for mechanistic insight and clinical translation. | Front Immunol | 2026 | https://conductscience.org/library/papers/42625977 | PubMed |
| 42275385 | A Lipid-Conjugation Strategy for Intracellular Reactive Oxygen Species Control in Hepatic Cells. | Angew Chem Int Ed Engl | 2026 | https://conductscience.org/library/papers/42275385 | PubMed |
| 41399350 | Metabolism-based artificial organelles: From precise construction to smart theranostics. | Mater Today Bio | 2025 | https://conductscience.org/library/papers/41399350 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41010669
GET https://conductscience.org/api/papers/v1/41010669/references?page=2